Industry Partners News

AxoGen, Inc. Announces Completion of a Pilot Clinical Study Assessing Cavernous Nerve Reconstruction with Avance® Nerve Graft Following Radical Prostatectomy

Study demonstrates technical feasibility and promising ability to restore erectile function and reduce incontinence. ALACHUA, FL – June 9, 2015 – AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral nerve repair market, announced results from… Read More